Source link : https://newshealth.biz/health-news/fda-restricts-gene-therapy-skysona-due-to-blood-cancer-risk/
(MedPage Today) — The FDA approved labeling changes for elivaldogene autotemcel (eli-cel; Skysona), a one-time gene therapy for patients with early, active cerebral adrenoleukodystrophy (CALD), to reflect new safety information about hematologic… Source link : https://www.medpagetoday.com/neurology/generalneurology/116922 Author : Publish date : 2025-08-08 21:27:00 Copyright for syndicated content belongs to the linked Source.
The post FDA Restricts Gene Therapy Skysona Due to Blood Cancer Risk first appeared on News Health.
—-
Author : News Health
Publish date : 2025-08-08 21:27:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8